Recent studies showed that changes in cytokine signaling networks, such as transforming growth factor (TGF-β), tumor necrosis factor (TNF), and interleukin (IL), contribute to tumor progression CRC [4]. The gene discussed is TNF; the disease is colorectal carcinoma.